US Broker Ratings

Waters Corporation (WAT) Stock Analysis: Navigating a 13.22% Potential Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with a market cap of $20.37 billion and a notable potential..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating Volatility with a 52-Week Range of $3.20 to $877.00

Regencell Bioscience Holdings Limited (RGC) stands out in the healthcare sector, particularly within the niche of Traditional Chinese Medicine (TCM) bioscience. While its market cap hovers around $7.74 billion, the..

GSK plc (GSK) Investor Outlook: Strong Dividend Yield and Strategic Growth in Healthcare

GSK plc (GSK), a stalwart in the healthcare sector and a major player in the drug manufacturing industry, offers investors a compelling mix of steady income and strategic growth potential...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Uncovering a 66% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector should consider Lantheus Holdings, Inc. (NASDAQ: LNTH), a company with a promising future reflected in its substantial potential upside. With a market capitalization..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating the Healthcare Distribution Landscape with an 8.78% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare distribution sector, presents an intriguing proposition for investors seeking a firm foothold in the medical distribution industry. With its..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 263% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX), a clinical-stage biotechnology company, has captured the attention of investors with its pioneering approach to vaccine development. Specializing in conjugate and novel protein vaccines, Vaxcyte is at..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 70% Upside Potential Sparks Investor Interest

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a prominent entity in the biotechnology sector, dedicated to the development and commercialization of therapies for rare diseases. With a market capitalization of..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth and Challenges with a 12.95% Upside

For investors seeking opportunities in the healthcare sector, Masimo Corporation (NASDAQ: MASI) presents an intriguing proposition. As a leading player in the medical devices industry, Masimo has carved a niche..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a Promising 4.77% Upside in the Diagnostics Sector

Qiagen N.V. (QGEN), a Netherlands-based leader in the healthcare sector, is carving a niche in the diagnostics and research industry with its innovative molecular insights solutions. With a market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 35.76% Upside Potential in the Healthcare Sector

For investors keen on the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling opportunity. With a market capitalization of $13.91 billion, this American company operates within the..

Inspire Medical Systems (INSP) Stock Analysis: Harnessing a 67.93% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the medical devices industry, is capturing attention with a significant potential upside of 67.93% based on current analyst ratings. Specializing..

Alkermes plc (ALKS) Investor Outlook: Analyzing a 33.87% Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, is drawing attention from investors with its significant potential upside of 33.87%, as indicated by the average target price..

STERIS plc (STE) Stock Analysis: Exploring the 9% Potential Upside in Healthcare Innovation

Investors with a keen eye on the healthcare sector might find STERIS plc (STE) an intriguing option. With its roots firmly planted in the medical devices industry, STERIS has carved..

Danaher Corporation (DHR) Stock Analysis: A 23% Upside Potential Awaits Investors

Danaher Corporation (NYSE: DHR), a leader in the healthcare sector, continues to captivate investor interest with its extensive portfolio in the diagnostics and research industry. With a market capitalization of..

Bruker Corporation (BRKR) Stock Analysis: 46% Potential Upside in Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector’s medical devices industry, is catching the eye of investors with its promising potential upside. With a market capitalization of..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Gem with 73.85% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands out in the biotechnology sector with its impressive pipeline and robust market presence. Based in Ireland, Jazz Pharmaceuticals specializes in the development and commercialization..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Growth Potential with a Robust Dividend Strategy

HCA Healthcare, Inc. (HCA) stands as a stalwart in the U.S. healthcare sector, boasting a formidable market cap of $89.3 billion. As a leader in the medical care facilities industry,..

Cencora, Inc. (COR) Investor Outlook: Navigating a 8.78% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector specializing in medical distribution, has captured investor attention with its robust market presence and promising growth indicators. As of..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 24.79% Upside Potential Amidst Market Challenges

Illumina, Inc. (NASDAQ: ILMN), a cornerstone in the healthcare sector, operates within the diagnostics and research industry. With a market cap of $13.76 billion, Illumina is a key player in..

Bio-Techne Corp (TECH) Stock Analysis: Unlocking 36.48% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) presents a compelling opportunity for investors seeking exposure to the burgeoning biotechnology sector. With a market capitalization of $7.92 billion, this Minneapolis-based company is a significant..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds